Company · CIK 0001059784 · SIC 2834 — Pharmaceutical Preparations
GENEREX BIOTECHNOLOGY CORP · GNBT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 7, 2018 PForm 4 → | Dec 14, 12:18 pm EST | Harold Gray HainesOther | 8,300 | $1.05 | $8,709 | 8,000 | — | plan? late |
| Dec 4, 2018 PForm 4 → | Dec 14, 2:31 pm EST | Harold Gray HainesOther | 1,500 | $2.11 | $3,169 | 945 | — | plan? late |
| Feb 16, 2016 MForm 4 → | Feb 16, 5:03 pm EST | David BrusegardChief Operating Officer | 1,667,671 | $0.001 | $1,668 | 5,615,070 | — | plan? |
| Feb 16, 2016 MForm 4 → | Feb 16, 5:02 pm EST | Mark FletcherPresident & CEO, Director | 4,447,111 | $0.001 | $4,447 | 15,821,836 | — | plan? |
| Feb 9, 2016 MForm 4 → | Feb 12, 4:10 pm EST | David BrusegardChief Operating Officer | 5,583,775 | $0.001 | $5,584 | 3,916,104 | — | plan? late |
| Feb 9, 2016 MForm 4 → | Feb 12, 4:08 pm EST | Mark FletcherPresident & CEO, Director | 14,890,033 | $0.001 | $14,890 | 10,442,992 | — | plan? late |
| Apr 27, 2015 MForm 4 → | Apr 27, 4:00 pm EDT | John P BarrattDirector | 5,874,162 | $0.001 | $5,874 | 5,874,162 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 3, 2018 AForm 4 → | Oct 15, 4:18 pm EDT | Andrew RoSVP & Chief Investment Officer, Director | 4,500 | — | — | 4,500 | — | late |
| Oct 3, 2018 AForm 4 → | Oct 15, 4:17 pm EDT | Richard David Purcell Jr.SVP of Research & Drug Develop, Director | 4,500 | — | — | 4,500 | — | late |
| Oct 3, 2018 AForm 4 → | Oct 15, 4:17 pm EDT | Brian McGeeDirector | 1,000 | — | — | 1,000 | — | late |
| Oct 3, 2018 AForm 4 → | Oct 15, 4:16 pm EDT | Gary Herbert LymanDirector | 1,000 | — | — | 1,000 | — | late |
| Oct 3, 2018 AForm 4 → | Oct 15, 4:16 pm EDT | Mark FletcherEVP General Counsel &Secretary | 4,500 | — | — | 4,500 | — | late |
| Oct 3, 2018 AForm 4 → | Oct 15, 4:15 pm EDT | Mark CorraoCFO & Treasurer | 4,500 | — | — | 4,500 | — | late |
| Oct 3, 2018 AForm 4 → | Oct 15, 4:15 pm EDT | Kevin CentofantiDirector | 1,000 | — | — | 1,000 | — | late |
| Oct 3, 2018 AForm 4 → | Oct 15, 4:14 pm EDT | James H Anderson Jr.Director | 1,000 | — | — | 1,000 | — | late |
| Feb 16, 2016 MForm 4 → | Feb 16, 5:03 pm EST | David BrusegardChief Operating Officer | 1,667,671 | — | — | 0 | — | |
| Feb 16, 2016 MForm 4 → | Feb 16, 5:02 pm EST | Mark FletcherPresident & CEO, Director | 4,447,111 | — | — | 0 | — | |
| Feb 9, 2016 MForm 4 → | Feb 12, 4:13 pm EST | Stephen FellowsChief Financial Officer | 1,667,671 | — | — | 1,667,671 | — | late |
| Feb 9, 2016 MForm 4 → | Feb 12, 4:11 pm EST | Eric Von HofePresident of Subsidiary, Director | 7,610,911 | — | — | 7,610,911 | — | late |
| Feb 9, 2016 MForm 4 → | Feb 12, 4:10 pm EST | David BrusegardChief Operating Officer | 5,583,775 | — | — | 1,667,671 | — | late |
| Feb 9, 2016 MForm 4 → | Feb 12, 4:08 pm EST | Mark FletcherPresident & CEO, Director | 12,635,393 | — | — | 4,447,111 | — | late |
| Apr 27, 2015 MForm 4 → | Apr 27, 4:00 pm EDT | John P BarrattDirector | 5,874,162 | — | — | 0 | — |